posted July 05, 2022 10:36 am by AveragePenny
(55)
The schedule for July 6, 2022, is as follows: (All times are Eastern Time Zone) We may see some schedule changes on Wednesday. To stay current on the schedule, please follow us on Twitter:
...read more
posted June 30, 2022 12:23 pm by AveragePenny
(55)
SOUTH EASTON, MA / ACCESSWIRE / June 30, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative
...read more
posted June 29, 2022 10:44 am by AveragePenny
(55)
SOUTH EASTON, MA / ACCESSWIRE / June 29, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling
...read more
posted June 14, 2022 10:45 am by AveragePenny
(55)
SOUTH EASTON, MA / ACCESSWIRE / June 14, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling
...read more
posted June 01, 2022 11:46 am by AveragePenny
(55)
Mr. Copley inquired further: "We have certainly been hearing and want to learn more about the successful launch of your UST Early Access Program. Please explain!" "UST, our latest
...read more
posted May 24, 2022 12:58 pm by AveragePenny
(55)
SOUTH EASTON, MA / ACCESSWIRE / May 24, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced that Emerging Technology Insider, a leading
...read more
posted May 19, 2022 12:15 pm by AveragePenny
(55)
Financial Highlights: Q1 2022 vs. Q1 2021 (rounded to nearest hundred except EPS) Total revenue for Q1 2022 was $480,000, reduced 14% from $560,000 for Q1 2021. Instrument sales for Q1
...read more
posted May 04, 2022 10:37 am by AveragePenny
(55)
SOUTH EASTON, MA / ACCESSWIRE / May 4, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling
...read more
posted May 03, 2022 11:24 am by AveragePenny
(55)
Company Invites Investors, Analysts, and Advisors to Attend Its In-Person and Webcast Presentation on Wednesday, May 4, 2022 at 11:30am PDT SOUTH EASTON, MA / ACCESSWIRE / May 3, 2022 /
...read more
posted April 27, 2022 12:27 pm by AveragePenny
(55)
SOUTH EASTON, MA / ACCESSWIRE / April 27, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling
...read more
posted April 20, 2022 12:42 pm by AveragePenny
(55)
Mr. Jolly began the interview by asking: "Could you please give my audience an update on the progress Pressure BioSciences is making towards the commercial release of your UST platform later this
...read more
posted April 20, 2022 10:40 am by AveragePenny
(55)
Phoenix, Arizona--(Newsfile Corp. - April 20, 2022) - The Stock Day Podcast welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or "the Company"), a leader in the development
...read more
posted April 19, 2022 11:52 am by AveragePenny
(55)
Company Invites Investors, Analysts, and Advisors to Attend Its Virtual Presentation on Wednesday, April 20th at 10:30am EDT SOUTH EASTON, MA / ACCESSWIRE / April 19, 2022 / Pressure
...read more
posted April 05, 2022 12:36 pm by AveragePenny
(55)
Financial Results: Q4 2021 vs. Q4 2020 Total revenue for Q4 2021 was $315,199 compared to $164,702 for the same period in 2020, a 91% increase. This increase was primarily due to our double-digit
...read more